<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01024374</url>
  </required_header>
  <id_info>
    <org_study_id>All-E-M-13244-01/02-10-09</org_study_id>
    <nct_id>NCT01024374</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face</brief_title>
  <acronym>13244/2009</acronym>
  <official_title>Avaliação da eficácia de um Produto de Uso tópico Contendo Hidrocortisona no Tratamento de Dermatite seborréica na Face.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergisa Pesquisa Dermato-Cosmetica LTDA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Galderma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Allergisa Pesquisa Dermato-Cosmetica LTDA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical single-blind randomized comparison with the overall objective of evaluating the
      clinical efficacy of the products Nutracort lotion and Nutracort cream in the treatment of
      seborrheic dermatitis on the face.

      Will be held clinical and perceived efficacy assessment and instrumental measurements. Each
      product will be applied at half face for 7 consecutive days and all applications will be
      monitored in the research site. 60 volunteers will be recruited.

      Evaluations will be held at the following times: T0 - before the initial application of the
      product; T1 - 24 hours after starting treatment, T2 - 48 hours after starting treatment, T3 -
      72 hours after initiation of treatment, T4 - 96 hours after the start treatment, T7 - 7 days
      after initiation of treatment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Seborrheic Dermatitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy subjects with seborrheic dermatitis on both sides of the face, both sexes, aged 18
        to 60 years, skin types I through IV.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects

          -  Subjects with seborrheic dermatitis on both sides of the face

          -  both sexes

          -  aged 18 to 60 years

          -  skin types I through IV.

        Exclusion Criteria:

          -  pregnancy / lactation

          -  skin condition in the area of application of the product

          -  diabetes

          -  immune insufficiency

          -  subjects that are using systemic corticoids

          -  subjects that are using immunosuppressors

          -  skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis

          -  history of reaction to the product category

          -  other diseases or medications that might interfere directly in the study or endanger
             the health of the subject
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2009</study_first_submitted>
  <study_first_submitted_qc>December 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2009</study_first_posted>
  <last_update_submitted>December 1, 2009</last_update_submitted>
  <last_update_submitted_qc>December 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Douglas - P&amp;D</name_title>
    <organization>Galderma</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Seborrheic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

